Latest news with #diagnosticTesting
Medscape
3 days ago
- Health
- Medscape
US Needs National Diagnostic Testing Plan for Public Health Threats
Allowing nontraditional laboratories to perform diagnostic testing in a potential pandemic situation was one of the nearly 100 actions proposed by a panel of experts, according to results of a new report published by the Government Accountability Office (GAO). The new report ultimately yielded four recommendations from the GAO to the Department of Health and Human Services (HHS), with two action items. One of these called for the creation of a national diagnostic testing strategy for infectious diseases with pandemic potential. Another called for the creation of a national diagnostic testing forum that would include a range of expert testing stakeholders from HHS and component agencies, but also the public and private sectors, nonprofit organizations, and academia. The other two main recommendations were that the national diagnostic testing strategy, once created, be updated regularly with lessons learned from infectious disease threats, other public health threats, or relevant preparedness exercises; and that the national diagnostic testing forum, once created, meet regularly, including both before and during infectious disease threats with pandemic potential, before and during other public health threats deemed relevant, or any related preparedness exercises. 'Pandemics pose an ever-present threat to American lives, national security, and economic interests, and diagnostic testing is critical to tracking infectious disease and helping reduce potential death rates,' said Mary Denigan-Macauley, director of Public Health for the GAO, in an interview. 'Testing helps us know where the disease is, how it is spreading and if it is gone,' Denigan-Macauley said. During the COVID-19 pandemic and the recent mpox outbreaks, the US Department of HHS struggled to lead the nation's testing efforts, and taking action to improve testing protocols now can boost preparedness for the next infectious disease emergency, Denigan-Macauley said. Diseases know no borders, she added. 'A strain of highly pathogenic avian influenza is widespread in wild birds around the globe and is already on our doorstep, causing outbreaks in poultry and US dairy cows, with several recent human cases in US dairy and poultry workers,' Denigan-Macauley said. 'Tracking these and other diseases is critical so we can be prepared and implement measures to control their spread,' she emphasized. Cooperative Planning Will Promote Current Information Infectious disease testing is not for the federal government to do alone; everyone from the doctor who tests the patient to local, state, and federal health officials should understand the national diagnostic testing strategy so they can work together, said Denigan-Macauley. 'We don't want key stakeholders working in silos that are fragmented and disjointed; this prevents us from understanding what is happening nationally to control a disease,' she said. 'A national diagnostic testing strategy and coordinating group could help the nation avoid some of the challenges faced during previous public health emergencies,' Denigan-Macauley told Medscape Medical News . 'For example, we found that the federal government did not always coordinate its updates to COVID-19 testing guidance with external stakeholders, such as healthcare professional organizations, which led to confusion and disagreement in the practice community,' she said. However, a national testing strategy could establish specific processes for coordination and collaboration related to testing guidance updates, she noted. 'A national coordinating group could then facilitate real-time communication of the updates, which would help ensure that frontline providers are prepared to implement new guidance upon its release,' she added. The current fragmented state of diagnostic testing efforts across numerous government agencies is a barrier to a national strategy, Denigan-Macauley told Medscape Medical News . 'Fragmentation refers to circumstances in which more than one agency is involved in the same broad area,' she said. 'Our states — simply by the way we are set up as a nation — also have differing capabilities, goals and their own health systems causing further fragmentation,' she explained. Establishing a testing coordinating group and implementing practices for interagency collaboration can help manage fragmentation and overcome this barrier, she said. Research Gaps The experts consulted on the report suggested several areas in need of additional research, including determining the types of diagnostic testing required for different types of pathogens, developing diagnostic tests with longer shelf lives, evaluating the new generations of diagnostic testing equipment, and understanding the human behaviors that drive compliance with diagnostic testing guidance, said Denigan-Macauley. A Specialist's Take Having a national diagnostic testing strategy would allow the US to cope more efficiently with the next pandemic, said Romney M. Humphries, PhD, D(ABMM), M(ASCP), professor of pathology, microbiology, and immunology at Vanderbilt University Medical Center, Nashville, Tennessee, in an interview. The COVID-19 pandemic was challenging in many ways, including the inability of many public health labs to handle the surge in testing needs, said Humphries. 'A national diagnostic testing strategy would promote building an infrastructure and developing partnerships among labs,' said Humphries. In addition, developing a universal approach to testing and standardized testing protocols, as are common in European countries, would streamline the process and facilitate such partnerships, she said. However, funding is a significant barrier to implementing any national diagnostic testing strategy, Humphries noted. Funding for various public health initiatives is being reduced or eliminated, but a national diagnostic testing strategy should be prioritized given the benefit to public health in general and the value in the event of a pandemic or other public health crisis, she said. Looking ahead, improvements in management and operations at the federal, state, and local level are needed to make a national diagnostic testing strategy successful, Humphries told Medscape Medical News . Although no action has yet been taken to create a national diagnostic testing strategy, 'HHS officials said they are taking some steps to improve diagnostic testing related to the actions suggested by experts,' according to the GAO website outlining the report.
Yahoo
27-05-2025
- Business
- Yahoo
Venipuncture Procedure Global Strategic Business Report 2025, with Profiles of Adam,Rouilly, CorVascular Diagnostics, Kyoto Kagaku, Smiths Medical, Sunphoria, Translite and more
Key insights highlight trends like patient-centered care and growing diagnostic testing needs. Technology advancements such as visualization tools enhance venipuncture procedures, offering safety and efficiency. The report includes analysis of major global markets like the U.S., China, and Europe, and examines recent global tariff impacts. E Venipuncture Procedure Market Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Venipuncture Procedure - Global Strategic Business Report" has been added to global market for Venipuncture Procedure was valued at US$1.1 Billion in 2024 and is projected to reach US$1.5 Billion by 2030, growing at a CAGR of 4.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Venipuncture Procedure market. Why Is Venipuncture Becoming a Focus in Healthcare Procedures?Venipuncture, the process of drawing blood from a vein, is a fundamental procedure in healthcare used for diagnostic testing, transfusions, and the administration of medications. As the demand for diagnostic testing increases, driven by the rise in chronic diseases, routine health check-ups, and the need for accurate and timely diagnoses, the importance of efficient and safe venipuncture procedures has grown. This procedure is essential in a wide range of medical settings, including hospitals, clinics, and laboratories, making it a critical component of patient care. The focus on improving the accuracy, safety, and patient experience during venipuncture is driving advancements in techniques, tools, and training, contributing to the growth of this Are the Emerging Trends in Venipuncture Procedures?The venipuncture procedure market is witnessing several emerging trends that are shaping its growth and development. One significant trend is the increasing focus on patient-centered care, where efforts are being made to reduce the discomfort and anxiety associated with venipuncture, particularly in pediatric and geriatric patients. Another trend is the growing use of vein visualization devices, such as near-infrared imaging, which enhances the accuracy of venipuncture by providing real-time images of the veins. The market is also seeing a rise in the adoption of safety-engineered needles and devices, designed to prevent needlestick injuries and reduce the risk of cross-contamination. Additionally, there is a growing emphasis on training and education for healthcare providers, with many institutions investing in simulation-based training to improve the proficiency and confidence of practitioners performing venipuncture. The increasing integration of digital health technologies, such as electronic medical records (EMRs) and mobile apps, is also emerging as a trend, facilitating better documentation and coordination of venipuncture Factors Are Driving the Growth of the Venipuncture Procedure Market?The growth in the venipuncture procedure market is driven by several factors, including the increasing demand for diagnostic testing, which requires frequent and reliable blood draws. The rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is also fueling the need for regular venipuncture procedures for monitoring and management. Additionally, the continuous advancements in venipuncture technology, including the development of safer and more effective needles and visualization devices, are expanding the market by improving procedural outcomes and patient satisfaction. The growing focus on patient safety and the need to reduce the risk of needlestick injuries and associated infections are further boosting demand for advanced venipuncture tools and techniques. Moreover, the increasing emphasis on improving the patient experience, particularly in sensitive populations such as children and the elderly, is contributing to the market's expansion as healthcare providers seek to offer more comfortable and less invasive venipuncture ScopeThe report analyzes the Venipuncture Procedure market, presented in terms of units. The analysis covers the key segments and geographic regions outlined Type (Median Cubital Vein, Cephalic Vein, Basilic Vein, Other Types) End-Use (Hospitals, Diagnostic Laboratories, Physicians' Offices, Other End-Uses) Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of Insights: Market Growth: Understand the significant growth trajectory of the Median Cubital Vein segment, which is expected to reach US$776.5 Million by 2030 with a CAGR of a 5.0%. The Cephalic Vein segment is also set to grow at 4.2% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $309.0 Million in 2024, and China, forecasted to grow at an impressive 4.0% CAGR to reach $228.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Adam,Rouilly Limited, CorVascular Diagnostics, Kyoto Kagaku Co., Ltd., Smiths Medical, Sunphoria Co. Ltd. and more. Tariff Impact Analysis: Key Insights for 2025Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Key Attributes: Report Attribute Details No. of Pages 194 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $1.1 Billion Forecasted Market Value (USD) by 2030 $1.5 Billion Compound Annual Growth Rate 4.4% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Tariff Impact on Global Supply Chain Patterns Global Economic Update Venipuncture Procedure - Global Key Competitors Percentage Market Share in 2024 Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 MARKET TRENDS & DRIVERS Rising Demand for Blood Sampling in Diagnostic Testing Technological Innovations in Venipuncture Devices and Techniques Growing Adoption of Automated and Minimally Invasive Venipuncture Systems Increasing Focus on Patient Safety and Comfort in Venipuncture Expansion of Venipuncture Procedures in Outpatient Settings Impact of Point-of-care Testing Trends on Venipuncture Demand Growing Demand for Portable and Mobile Venipuncture Devices Rising Awareness and Adoption of Infection Control Measures Impact of Home Healthcare Trends on Venipuncture Procedure Adoption FOCUS ON SELECT PLAYERS Some of the 41 companies featured in this Venipuncture Procedure market report include: Adam,Rouilly Limited CorVascular Diagnostics Kyoto Kagaku Co., Ltd. Smiths Medical Sunphoria Co. Ltd. Translite For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Venipuncture Procedure Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Daily Mail
11-05-2025
- Business
- Daily Mail
Blood testing fraudster Elizabeth Holmes' husband unveils his VERY ironic new business
While his wife Elizabeth Holmes is in jail for defrauding investors through her blood-testing company, Billy Evans is ironically starting his own. Evans is launching a business which also aims to revolutionize diagnostic testing using bodily fluids, according to marketing materials seen by the New York Times. The entrepreneur is in the fundraising stage of creating a start-up called Haemanthus, which is the Greek name of a flower also known as a blood lily. Evans wasn't planning on announcing his nascent venture yet, but two investors who he pitched to spoke anonymously about the plans with the New York Times. His company - which comes 22 years after Holmes launched her own phony business named Theranos - is aiming to raise $50 million to create a medical testing product which would hope to catalyze 'human health optimization.' Evans, who shares two children with Holmes, has reportedly raised a few million for the project so far, but it's unclear what the timeline for the company launch is. He told the Times that 'when you're in stealth, you're trying to be in stealth. (You) aren't going to find anything associated with the name Haemanthus'. The Times shared a photograph allegedly showing the medical device Haemanthus is creating, which looks very similar to Holmes' Edison testing machine. Evans, who shares two children with Holmes, has reportedly raised a few million for the project so far, but it's unclear what the timeline for the company launch is Theranos founder Holmes, 41, has served two out of her 11-year sentence at Federal Prison Camp in Bryan, Texas, after she was convicted on fraud charges in January 2022. She founded what seemed to be a revolutionary blood-testing company called Theranos after dropping out of Stanford University at the age of 19. The company's valuation skyrocketed to $9 billion after it claimed to have developed methods which required just a droplet of blood from a finger-prick. Forbes named Holmes the youngest female self-made billionaire in the US in 2015. But her Silicon Valley success came crashing down the following year when a series of explosive articles in The Wall Street Journal laid bare her lies to investors. Holmes managed to gain investment in her company by lying about the accuracy and reliability of her blood-testing equipment, a jury found in January 2022. As it currently stands, Holmes is due to be released early on December 29, 2032 - just over 9.5 years after she began her prison sentence. She met husband Evans, who is nine years her junior, at a party in 2017 just as Theranos was collapsing. According to the New York Post, Billy told a former colleague: 'You won't believe who I met! She's not as the articles portray her to be.' The pair's relationship progressed quickly, despite Holmes' legal troubles. They adopted a husky together, and were spotted at Burning Man in 2018, and he stood by her side throughout her court hearings. Last February, Holmes was spotted celebrating her 40th birthday behind bars. At the time, she was seen playing in the prison yard with her other half Billy and their children at FPC Bryan in Texas. Dressed in her prison-issued khakis, Holmes couldn't contain her joy and smiled as she held her son and was visited by her parents and friends. The multi-million dollar pharmaceutical scammer has allegedly been doing workout classes and spending time with her fellow high-profile inmate, Real Housewives of Salt Lake City star Jen Shah. She has also been taking maternal advice from Shah, with sources previously claiming that they have been helping each other 'get through' their incarcerations. Comedian Nathan Fielder has also been spotted visiting Holmes in the high-security prison, according to Jeff Sneider of The Insneider. Fielder hasn't shared any details about his trips to the federal jail, but Sneider's report suggests the comedian may be working on a documentary or some kind of experimental video project. Holmes' life has also been dramatized through BBC1 series The Dropout, which launched last year.
